Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,655 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T. Terakura S, et al. Among authors: ohashi k. Bone Marrow Transplant. 2017 Mar;52(3):423-430. doi: 10.1038/bmt.2016.255. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941766
Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.
Yamasaki S, Aoki J, Mori J, Mizuno S, Uchida N, Ohashi K, Fukuda T, Ikegame K, Eto T, Ogawa Y, Tanaka M, Hidaka M, Iwato K, Sawa M, Ichinohe T, Kanda Y, Atsuta Y, Yanada M, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Yamasaki S, et al. Among authors: ohashi k. Bone Marrow Transplant. 2020 Jan;55(1):249-252. doi: 10.1038/s41409-019-0527-z. Epub 2019 Apr 10. Bone Marrow Transplant. 2020. PMID: 30971777 No abstract available.
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M; GVHD working group of the Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Among authors: ohashi k. Bone Marrow Transplant. 2016 Jan;51(1):96-102. doi: 10.1038/bmt.2015.205. Epub 2015 Sep 14. Bone Marrow Transplant. 2016. PMID: 26367230 Clinical Trial.
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT.
Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J. Nishiwaki S, et al. Among authors: ohashi k. Bone Marrow Transplant. 2016 Jan;51(1):43-50. doi: 10.1038/bmt.2015.217. Epub 2015 Sep 21. Bone Marrow Transplant. 2016. PMID: 26389833 Clinical Trial.
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M. Kanda J, et al. Among authors: ohashi k. Leukemia. 2017 Mar;31(3):663-668. doi: 10.1038/leu.2016.288. Epub 2016 Oct 17. Leukemia. 2017. PMID: 27748373
A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.
Fuji S, Kim SW, Yano S, Hagiwara S, Nakamae H, Hidaka M, Ito T, Ohashi K, Hatanaka K, Takami A, Kurosawa S, Yamashita T, Yamaguchi T, Fukuda T. Fuji S, et al. Among authors: ohashi k. Bone Marrow Transplant. 2016 Mar;51(3):451-3. doi: 10.1038/bmt.2015.268. Epub 2015 Nov 9. Bone Marrow Transplant. 2016. PMID: 26551777 Clinical Trial. No abstract available.
2,655 results